Navigation Links
Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors
Date:11/21/2013

y into underlying elements in the Warburg Hypothesis. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the discovery platform that translates biological output into viable therapeutics and a robust biomarker library, Berg is poised to realize its pursuit of a healthier tomorrow. For additional information, visit http://www.bergpharma.com/.

Media Contact:
Alisha Tischler
Ogilvy Public Relations
212-880-5218
alisha.tischler@ogilvy.com

Investor Contact:
Tom Smith
Ogilvy Public Relations
212-880-5269
tom.smith@ogilvy.com


'/>"/>
SOURCE Berg
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Linguamatics Launches Healthcare Product Suite to Turn Unstructured Electronic Health Record Data into Actionable Patient Insights
2. M&G Chemicals Launches Green Revolution in the Polyester Chain
3. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
4. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
5. Goldstone Scientific Launches, Offering an Easy Shopping Experience for Prizmatix Ultra High Power LED Systems
6. $100 Million Gift Launches Sanford Stem Cell Clinical Center
7. ISPE Launches New Expanded E-Learning Courses
8. Tute Genomics Launches at 2013 ASHG Conference
9. Trade Show Display Co. GLM Displays Launches New “Customer Spotlight” Campaign
10. How Companies Can Provide Extraordinary New B2B Products with Extraordinary Product Launches - A Sales Momentum White Paper
11. QB3 Launches New Biotech Incubator in San Francisco with 24 Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Knowledgent , the ... the opportunities for advanced analytics utilizing data lakes in the healthcare industry. , As ... seen an explosion of data over the last few years as more entities become ...
(Date:9/1/2015)... ... September 01, 2015 , ... Research conducted by ... Angeles, Boston University School of Medicine, Frederick National Laboratory for Cancer Research, and ... first multidisciplinary Open Access journal. , Christopher Ryan PhD, of Synedgen, and ...
(Date:8/31/2015)... Aug. 31, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... million. The orders are for air emission abatement projects in ... is a large order for a municipality in the ... replacing a competitor,s system that failed to meet the customer,s ... solutions," said Derek S. Webb , President and Chief ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... Sensors market is estimated at $0.20 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
Breaking Biology Technology:New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Mexico Biomedical Sensors Market Report 2015-2020 2
... ground-breaking treatment option for victims of whiplash associated disorders (WAD). ... Z Therapy is the first and only rehabilitation specialist in North ... neck pain. , ... Dallas, TX (PRWEB) April 21, ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the first quarter ... before the opening of the financial markets.NxStage will also ... on Friday, May 8, 2009 to discuss its first ...
... LLC announced today that it has issued an Executive ... 56-page report can be found at www.crystalra.com ... is a closely held pharmaceutical company focused exclusively on ... a technology spinout from Bayer HealthCare LLC, ACT Biotech ...
Cached Biology Technology:Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers 2NxStage to Report First Quarter 2009 Financial Results 2Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 2Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 3
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... Chine, 31 juillet 2015 La 10e ... ) sera organisée par le BGI du 22 ... en Chine. La conférence ... inauguration en 2006, l,ICG est devenue l,une des ... domaine des « omiques » et c,est aussi la plus ...
(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... the most abundant biomass material on Earth, and therefore ... for the production of advance biofuels. A major roadblock, ... Researchers with the U.S. Department of Energy (DOE),s Joint ... removing this roadblock by identifying a gene in rice ...
... experts from around the world in Clinical Rehabilitation, Applied ... to 16th, at the First International Conference on NeuroRehabilitation ... conference, organized in Toledo (Spain) by researchers of the ... state of the therapies that are currently being conducted ...
... 2012) John Wiley & Sons, Inc., (NYSE:JWa, JWb), ... areas of scientific, technical, medical, and scholarly research; professional ... TED, the non-profit devoted to Ideas Worth Spreading, to ... series of "TED Studies." To support the ...
Cached Biology News:A better route to xylan 2A better route to xylan 3Leader experts in neurorehabilitation gather in Toledo, Spain 2Wiley Partners with TED 2
... Specificity: This antibody recognizes murine ... cross-react with other related IRF ... with murine IRF7 protein was ... of the 293T cells transfected ...
... PS603. Immunogen: Synthetic phosphopeptide ... the phosphorylated Ser603 residue of ... Specific for synapsin I when ... Reactivity: Rat (positive control: ...
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
karyopherin alpha2 (2G7)...
Biology Products: